<p><strong>IO Biotech, Inc.</strong> 的股票 (NASDAQ: IOBT] 周二暴跌，此前该公司宣布申请第七章破产，并将 停止在特拉华州的运营。</p>
<ul>
<li>IO Biotech 的股票接近关键低点。是什么导致 IOBT 受压？</li>
</ul>
<h2>IO Biotech 宣布破产，股票创下新低</h2>
<p>IO Biotech 的抛售被视为破产事件，而非常规的小型生物科技去风险化，此前该公司申请了第七章破产，并表示将停止在特拉华州的运营。该股票在这一消息披露后下跌约 73%，至大约 0.046 美元。</p>
<p>这一价格走势与一只长期处于下行趋势的股票一致，现在正在突破新低，这可能引发强制卖出和流动性驱动的空头。随着其他小型股风险偏好的改善（罗素 2000 指数上涨 2.05%，市场广度积极，9 个行业上涨），这种脱节指向的是股票特定的定位和技术损伤，而非行业整体的变动。</p>
<p>从图表的角度来看，IOBT 的交易价格远低于其关键趋势指标，因此即使是适度的卖压也可能在没有附近技术 “支撑” 的情况下产生过大的影响。当一只股票正在创下新低且之前的支撑位已经失效时，这种动态通常会显现出来。</p>
<h2>股票交易远低于关键平均线</h2>
<p>IOBT 的交易价格比其 20 日简单移动平均线（23 美分）低 81.5%，比其 100 日 SMA（51 美分）低 91.6%，使得短期和中期趋势均保持明显看跌。过去 12 个月，股票下跌了 96.09%，目前的位置更接近其 52 周低点而非高点。</p>
<p>RSI 在 30–50 范围内，伴随看涨的 MACD 指标，表明动能偏向看涨，但它正在与深度看跌的趋势背景作斗争。当前的关键阻力位在 50 美分，鉴于急剧的抛售，没有明确的支撑位。</p>
<h2>股票创下新低</h2>
<p><strong>IOBT 股票价格活动：</strong> 根据 Benzinga Pro 数据，在周二发布时，IO Biotech 的股票下跌 75.41%，报 0.045 美元。</p>
<p><em>图片来源：Shutterstock</em></p>

标普生物技术 3 倍做空 - Direxion

IBBQ

标普生物技术 ETF - SPDR

<p>IO Biotech, Inc.（纳斯达克代码：IOBT）的股票在公司申请第七章破产并将在特拉华州停止运营后暴跌。该股下跌约 73%，至大约 0.046 美元，反映出市场对这一破产事件的显著抛售。IOBT 的交易价格远低于关键平均水平，过去一年下跌了 96.09%，且没有明确的支撑位。尽管有一些看涨的动量指标，但整体趋势依然深度看跌，关键阻力位在 50 美分</p>

<p>Shares of <strong>IO Biotech, Inc.</strong> (NASDAQ: IOBT) are plummeting Tuesday after the company announced it filed for Chapter 7 bankruptcy and will cease operations in Delaware.</p>
<div class="lb-trans"><p><strong>IO Biotech, Inc.</strong> 的股票 (NASDAQ: IOBT] 周二暴跌，此前该公司宣布申请第七章破产，并将 停止在特拉华州的运营。</p>
</div><ul>
<li>IO Biotech shares are approaching critical lows. What’s pressuring IOBT?</li>
</ul>
<div class="lb-trans"><ul>
<li>IO Biotech 的股票接近关键低点。是什么导致 IOBT 受压？</li>
</ul>
</div><h2>Shares Hit New Low As IO Biotech Declares Bankruptcy</h2>
<div class="lb-trans"><h2>IO Biotech 宣布破产，股票创下新低</h2>
</div><p>IO Biotech's sell-off is being treated as an insolvency event, not a routine small-cap biotech de-risking, after the company filed for Chapter 7 bankruptcy and said it will cease operations in Delaware. The stock fell about 73% to roughly $0.046 alongside that disclosure.</p>
<div class="lb-trans"><p>IO Biotech 的抛售被视为破产事件，而非常规的小型生物科技去风险化，此前该公司申请了第七章破产，并表示将停止在特拉华州的运营。该股票在这一消息披露后下跌约 73%，至大约 0.046 美元。</p>
</div><p>The price action is consistent with a stock that has been in a prolonged downtrend and is now breaking to fresh lows, which can trigger forced selling and liquidity-driven air pockets. With small-cap risk appetite improving elsewhere (Russell 2000 up 2.05% and market breadth positive with 9 sectors advancing), the disconnect points to stock-specific positioning and technical damage rather than a sector-wide move.</p>
<div class="lb-trans"><p>这一价格走势与一只长期处于下行趋势的股票一致，现在正在突破新低，这可能引发强制卖出和流动性驱动的空头。随着其他小型股风险偏好的改善（罗素 2000 指数上涨 2.05%，市场广度积极，9 个行业上涨），这种脱节指向的是股票特定的定位和技术损伤，而非行业整体的变动。</p>
</div><p>From a chart perspective, IOBT is also trading far below its key trend gauges, so even modest selling pressure can have an outsized impact when there's no nearby technical &#34;floor&#34; traders trust. That dynamic often shows up when a name is pressing new lows and prior support levels have already failed.</p>
<div class="lb-trans"><p>从图表的角度来看，IOBT 的交易价格远低于其关键趋势指标，因此即使是适度的卖压也可能在没有附近技术 “支撑” 的情况下产生过大的影响。当一只股票正在创下新低且之前的支撑位已经失效时，这种动态通常会显现出来。</p>
</div><h2>Shares Trade Far Below Key Averages</h2>
<div class="lb-trans"><h2>股票交易远低于关键平均线</h2>
</div><p>IOBT is trading 81.5% below its 20-day simple moving average (23 cents) and 91.6% below its 100-day SMA (51 cents), keeping both the short- and intermediate-term trends firmly bearish. Shares are down 96.09% over the past 12 months and are positioned much closer to their 52-week lows than highs.</p>
<div class="lb-trans"><p>IOBT 的交易价格比其 20 日简单移动平均线（23 美分）低 81.5%，比其 100 日 SMA（51 美分）低 91.6%，使得短期和中期趋势均保持明显看跌。过去 12 个月，股票下跌了 96.09%，目前的位置更接近其 52 周低点而非高点。</p>
</div><p>RSI in the 30–50 range with bullish MACD indicates momentum leaning bullish, but it's fighting a deeply bearish trend backdrop. Key resistance currently sits at 50 cents with no clear support defined given the sharp sell-off.</p>
<div class="lb-trans"><p>RSI 在 30–50 范围内，伴随看涨的 MACD 指标，表明动能偏向看涨，但它正在与深度看跌的趋势背景作斗争。当前的关键阻力位在 50 美分，鉴于急剧的抛售，没有明确的支撑位。</p>
</div><h2>Shares Hit New Low</h2>
<div class="lb-trans"><h2>股票创下新低</h2>
</div><p><strong>IOBT Stock Price Activity:</strong> IO Biotech shares were down 75.41% at $0.045 at the time of publication on Tuesday, according to Benzinga Pro data.</p>
<div class="lb-trans"><p><strong>IOBT 股票价格活动：</strong> 根据 Benzinga Pro 数据，在周二发布时，IO Biotech 的股票下跌 75.41%，报 0.045 美元。</p>
</div><p><em>Image: Shutterstock</em></p>
<div class="lb-trans"><p><em>图片来源：Shutterstock</em></p>
</div>

为什么 IO Biotech 的股价大幅下跌？